Breast cancer specialists at NewYork-Presbyterian Hospital/Columbia University Medical Center are offering patients new ways to detect early signs of lymphedema, a common side effect of breast cancer surgery that causes painful, debilitating and disfiguring swelling in the arms following removal of lymph nodes.

NewYork-Presbyterian Hospital and Columbia University Medical Center have entered into a strategic collaboration to manage the electronic health record (EHR) system for ColumbiaDoctors, the Columbia faculty practice organization and one of the largest multi-specialty practices in the Northeast.

An experimental therapy that may prevent the death of dopamine neurons in patients with Parkinson's disease is now being tested at NewYork-Presbyterian Hospital/Columbia University Medical Center and 10 other leading medical centers around the country.

Surgeons at NewYork–Presbyterian Hospital/Columbia University Medical Center are innovating new ways to treat diabetes using techniques from weight–loss surgery, including experimental procedures to improve blood glucose levels and address a major complication of the disease.

An internationally recognized expert in the emerging field of interventional oncology, Dr. David C. Madoff has been named chief of interventional radiology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. He was also appointed as professor of radiology at Weill Cornell Medical College.

NewYork-Presbyterian Hospital/Columbia University Medical Center today became the first in the United States to implant the SAPIEN transcatheter aortic heart valve as an FDA-approved standard of care. This major advance in patient care follows the FDA's decision on Nov. 2 to approve SAPIEN as a preferred treatment for patients too sick to undergo traditional aortic valve surgery.

Using a sophisticated imaging test to probe for higher-level cognitive functioning in severely brain-injured patients provides a window into consciousness -- but the view it presents is one that is blurred in fascinating ways, say researchers at Weill Cornell Medical College in the Feb. 25 online edition of the journal Brain.

A new clinical trial at NewYork-Presbyterian Hospital/Weill Cornell Medical Center is among the first to test surgery specifically for Type 2 diabetes. The aim of the study is to understand whether surgery can control diabetes, as well or even better than the best medical treatment available today. This is the first study of its kind open to patients who are overweight or mildly obese.